Psychiatric gene discoveries shape evidence on ADHD's biology

A. Thapar, J Martin, E. Mick, A. Arias Vásquez, K Langley, S W Scherer, R. Schachar, J Crosbie, N Williams, B. Franke, J. Elia, J. Glessner, H. Hakonarson, IMAGE 2 Consortium, M J Owen, S. V. Faraone, M. C. O'Donovan, P. Holmans

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Abstract

A strong motivation for undertaking psychiatric gene discovery studies is to provide novel insights into unknown biology. Although attention-deficit hyperactivity disorder (ADHD) is highly heritable, and large, rare copy number variants (CNVs) contribute to risk, little is known about its pathogenesis and it remains commonly misunderstood. We assembled and pooled five ADHD and control CNV data sets from the United Kingdom, Ireland, United States of America, Northern Europe and Canada. Our aim was to test for enrichment of neurodevelopmental gene sets, implicated by recent exome-sequencing studies of (a) schizophrenia and (b) autism as a means of testing the hypothesis that common pathogenic mechanisms underlie ADHD and these other neurodevelopmental disorders. We also undertook hypothesis-free testing of all biological pathways. We observed significant enrichment of individual genes previously found to harbour schizophrenia de novo non-synonymous single-nucleotide variants (SNVs; P=5.4 × 10-4) and targets of the Fragile X mental retardation protein (P=0.0018). No enrichment was observed for activity-regulated cytoskeleton-associated protein (P=0.23) or N-methyl-D-aspartate receptor (P=0.74) post-synaptic signalling gene sets previously implicated in schizophrenia. Enrichment of ADHD CNV hits for genes impacted by autism de novo SNVs (P=0.019 for non-synonymous SNV genes) did not survive Bonferroni correction. Hypothesis-free testing yielded several highly significantly enriched biological pathways, including ion channel pathways. Enrichment findings were robust to multiple testing corrections and to sensitivity analyses that excluded the most significant sample. The findings reveal that CNVs in ADHD converge on biologically meaningful gene clusters, including ones now established as conferring risk of other neurodevelopmental disorders.
Original languageEnglish
Pages (from-to)1202-1207
Number of pages6
JournalMolecular Psychiatry
Volume21
Issue number9
DOIs
Publication statusPublished - 1 Sep 2016

Cite this

Thapar, A., Martin, J., Mick, E., Arias Vásquez, A., Langley, K., Scherer, S. W., ... Holmans, P. (2016). Psychiatric gene discoveries shape evidence on ADHD's biology. Molecular Psychiatry, 21(9), 1202-1207. https://doi.org/10.1038/mp.2015.163
Thapar, A. ; Martin, J ; Mick, E. ; Arias Vásquez, A. ; Langley, K ; Scherer, S W ; Schachar, R. ; Crosbie, J ; Williams, N ; Franke, B. ; Elia, J. ; Glessner, J. ; Hakonarson, H. ; IMAGE 2 Consortium ; Owen, M J ; Faraone, S. V. ; O'Donovan, M. C. ; Holmans, P. / Psychiatric gene discoveries shape evidence on ADHD's biology. In: Molecular Psychiatry. 2016 ; Vol. 21, No. 9. pp. 1202-1207.
@article{357fab70fef442f48a9cc64fbf360ccd,
title = "Psychiatric gene discoveries shape evidence on ADHD's biology",
abstract = "A strong motivation for undertaking psychiatric gene discovery studies is to provide novel insights into unknown biology. Although attention-deficit hyperactivity disorder (ADHD) is highly heritable, and large, rare copy number variants (CNVs) contribute to risk, little is known about its pathogenesis and it remains commonly misunderstood. We assembled and pooled five ADHD and control CNV data sets from the United Kingdom, Ireland, United States of America, Northern Europe and Canada. Our aim was to test for enrichment of neurodevelopmental gene sets, implicated by recent exome-sequencing studies of (a) schizophrenia and (b) autism as a means of testing the hypothesis that common pathogenic mechanisms underlie ADHD and these other neurodevelopmental disorders. We also undertook hypothesis-free testing of all biological pathways. We observed significant enrichment of individual genes previously found to harbour schizophrenia de novo non-synonymous single-nucleotide variants (SNVs; P=5.4 × 10-4) and targets of the Fragile X mental retardation protein (P=0.0018). No enrichment was observed for activity-regulated cytoskeleton-associated protein (P=0.23) or N-methyl-D-aspartate receptor (P=0.74) post-synaptic signalling gene sets previously implicated in schizophrenia. Enrichment of ADHD CNV hits for genes impacted by autism de novo SNVs (P=0.019 for non-synonymous SNV genes) did not survive Bonferroni correction. Hypothesis-free testing yielded several highly significantly enriched biological pathways, including ion channel pathways. Enrichment findings were robust to multiple testing corrections and to sensitivity analyses that excluded the most significant sample. The findings reveal that CNVs in ADHD converge on biologically meaningful gene clusters, including ones now established as conferring risk of other neurodevelopmental disorders.",
author = "A. Thapar and J Martin and E. Mick and {Arias V{\'a}squez}, A. and K Langley and Scherer, {S W} and R. Schachar and J Crosbie and N Williams and B. Franke and J. Elia and J. Glessner and H. Hakonarson and {IMAGE 2 Consortium} and Owen, {M J} and Faraone, {S. V.} and O'Donovan, {M. C.} and P. Holmans and Ziarih Hawi",
year = "2016",
month = "9",
day = "1",
doi = "10.1038/mp.2015.163",
language = "English",
volume = "21",
pages = "1202--1207",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "9",

}

Thapar, A, Martin, J, Mick, E, Arias Vásquez, A, Langley, K, Scherer, SW, Schachar, R, Crosbie, J, Williams, N, Franke, B, Elia, J, Glessner, J, Hakonarson, H, IMAGE 2 Consortium, Owen, MJ, Faraone, SV, O'Donovan, MC & Holmans, P 2016, 'Psychiatric gene discoveries shape evidence on ADHD's biology', Molecular Psychiatry, vol. 21, no. 9, pp. 1202-1207. https://doi.org/10.1038/mp.2015.163

Psychiatric gene discoveries shape evidence on ADHD's biology. / Thapar, A.; Martin, J; Mick, E.; Arias Vásquez, A.; Langley, K; Scherer, S W; Schachar, R.; Crosbie, J; Williams, N; Franke, B.; Elia, J.; Glessner, J.; Hakonarson, H.; IMAGE 2 Consortium; Owen, M J; Faraone, S. V.; O'Donovan, M. C.; Holmans, P.

In: Molecular Psychiatry, Vol. 21, No. 9, 01.09.2016, p. 1202-1207.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Psychiatric gene discoveries shape evidence on ADHD's biology

AU - Thapar, A.

AU - Martin, J

AU - Mick, E.

AU - Arias Vásquez, A.

AU - Langley, K

AU - Scherer, S W

AU - Schachar, R.

AU - Crosbie, J

AU - Williams, N

AU - Franke, B.

AU - Elia, J.

AU - Glessner, J.

AU - Hakonarson, H.

AU - IMAGE 2 Consortium

AU - Owen, M J

AU - Faraone, S. V.

AU - O'Donovan, M. C.

AU - Holmans, P.

AU - Hawi, Ziarih

PY - 2016/9/1

Y1 - 2016/9/1

N2 - A strong motivation for undertaking psychiatric gene discovery studies is to provide novel insights into unknown biology. Although attention-deficit hyperactivity disorder (ADHD) is highly heritable, and large, rare copy number variants (CNVs) contribute to risk, little is known about its pathogenesis and it remains commonly misunderstood. We assembled and pooled five ADHD and control CNV data sets from the United Kingdom, Ireland, United States of America, Northern Europe and Canada. Our aim was to test for enrichment of neurodevelopmental gene sets, implicated by recent exome-sequencing studies of (a) schizophrenia and (b) autism as a means of testing the hypothesis that common pathogenic mechanisms underlie ADHD and these other neurodevelopmental disorders. We also undertook hypothesis-free testing of all biological pathways. We observed significant enrichment of individual genes previously found to harbour schizophrenia de novo non-synonymous single-nucleotide variants (SNVs; P=5.4 × 10-4) and targets of the Fragile X mental retardation protein (P=0.0018). No enrichment was observed for activity-regulated cytoskeleton-associated protein (P=0.23) or N-methyl-D-aspartate receptor (P=0.74) post-synaptic signalling gene sets previously implicated in schizophrenia. Enrichment of ADHD CNV hits for genes impacted by autism de novo SNVs (P=0.019 for non-synonymous SNV genes) did not survive Bonferroni correction. Hypothesis-free testing yielded several highly significantly enriched biological pathways, including ion channel pathways. Enrichment findings were robust to multiple testing corrections and to sensitivity analyses that excluded the most significant sample. The findings reveal that CNVs in ADHD converge on biologically meaningful gene clusters, including ones now established as conferring risk of other neurodevelopmental disorders.

AB - A strong motivation for undertaking psychiatric gene discovery studies is to provide novel insights into unknown biology. Although attention-deficit hyperactivity disorder (ADHD) is highly heritable, and large, rare copy number variants (CNVs) contribute to risk, little is known about its pathogenesis and it remains commonly misunderstood. We assembled and pooled five ADHD and control CNV data sets from the United Kingdom, Ireland, United States of America, Northern Europe and Canada. Our aim was to test for enrichment of neurodevelopmental gene sets, implicated by recent exome-sequencing studies of (a) schizophrenia and (b) autism as a means of testing the hypothesis that common pathogenic mechanisms underlie ADHD and these other neurodevelopmental disorders. We also undertook hypothesis-free testing of all biological pathways. We observed significant enrichment of individual genes previously found to harbour schizophrenia de novo non-synonymous single-nucleotide variants (SNVs; P=5.4 × 10-4) and targets of the Fragile X mental retardation protein (P=0.0018). No enrichment was observed for activity-regulated cytoskeleton-associated protein (P=0.23) or N-methyl-D-aspartate receptor (P=0.74) post-synaptic signalling gene sets previously implicated in schizophrenia. Enrichment of ADHD CNV hits for genes impacted by autism de novo SNVs (P=0.019 for non-synonymous SNV genes) did not survive Bonferroni correction. Hypothesis-free testing yielded several highly significantly enriched biological pathways, including ion channel pathways. Enrichment findings were robust to multiple testing corrections and to sensitivity analyses that excluded the most significant sample. The findings reveal that CNVs in ADHD converge on biologically meaningful gene clusters, including ones now established as conferring risk of other neurodevelopmental disorders.

UR - http://www.scopus.com/inward/record.url?scp=84947087617&partnerID=8YFLogxK

U2 - 10.1038/mp.2015.163

DO - 10.1038/mp.2015.163

M3 - Article

VL - 21

SP - 1202

EP - 1207

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 9

ER -

Thapar A, Martin J, Mick E, Arias Vásquez A, Langley K, Scherer SW et al. Psychiatric gene discoveries shape evidence on ADHD's biology. Molecular Psychiatry. 2016 Sep 1;21(9):1202-1207. https://doi.org/10.1038/mp.2015.163